These findings indicate that Notch3 is an important regulator of aortic SMC function and differentiation during aortic development and suggest that therapy modulating Notch3 signaling in the aorta may be beneficial in inhibiting aortic aneurysm formation in MFS. This evidence concerns the gene NOTCH3 and aortic aneurysm.